Protection against tetanus toxin using a plant-based vaccine

European Journal of Immunology

Volumn 35, Issue 4, 2005, Pages 1320-1326

  Tregoning, John S ^a,b   Clare, Simon ^a   Bowe, Frances ^a   Edwards, Lorna ^a   Fairweather, Neil ^a   Qazi, Omar ^a   Nixon, Peter J ^a   Maliga, Pal ^b   Dougan, Gordon ^a   Hussell, Tracy ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Mucosal; Plastid transformation; T cell; Tetanus toxin fragment C

Indexed keywords

CD4 ANTIGEN; CHOLERA TOXIN; TETANUS ANTIBODY; VEGETABLE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BYSTANDER EFFECT; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNITY; MOUSE; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TETANUS; THERMOSTABILITY; TOBACCO; VACCINATION;

ANIMALS; MICE; TETANUS TOXIN; TOBACCO; VACCINES;

EID: 20244362925     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425453     Document Type: Article

References (27)

1. Simonsen, L., Kane, A., Lloyd, J., Zaffran, M. and Kane, M., Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull. World Health Organ. 1999. 77: 789-800.
2. WHO, EPI Information Systems: Global summary, September 1998. WHO, Geneva 1998
3. WHO, Maternal and Neonatal Tetanus Elimination by 2005. Strategies for achieving and maintaining elimination. WHO, Geneva 2000
4. Haq, T. A., Mason, H. S., Clements, J. D. and Arntzen, C. J., Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 1995. 268: 714-716.
5. Chikwamba, R. K., Scott, M. P., Mejia, L. B., Mason, H. S. and Wang, K., Localization of a bacterial protein in starch granules of transgenic maize kernels. Proc. Natl. Acad. Sci. USA 2003. 100: 11127-11132.
6. Mason, H. S., Ball, J. M., Shi, J. J., Jiang, X., Estes, M. K. and Arntzen, C. J., Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity to mice. Proc. Natl. Acad. Sci. USA 1996. 93: 5335-5340.
7. Tacket, C. O., Mason, H. S., Losonsky, G., Estes, M. K., Levine, M. M. and Arntzen, C. J., Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 2000. 182: 302-305.
8. Mason, H. S., Lam, D. M. and Arntzen, C. J., Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl. Acad. Sci. USA 1992. 89: 11745-11749.
9. Thanavala, Y., Yang, Y. F., Lyons, P., Mason, H. S. and Arntzen, C., Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA 1995. 92: 3358-3361.
10. Kong, Q., Richter, L., Yang, Y. F., Arntzen, C. J., Mason, H. S. and Thanavala, Y., Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Natl. Acad. Sci. USA 2001. 98: 11539-11544.
11. Yu, J. and Langridge, W. H., A plant-based multicomponent vaccine protects mice from enteric diseases. Nat. Biotechnol. 2001. 19: 548-552.
12. Ma, J. K., Drake, P. M. and Christou, P., The production of recombinant pharmaceutical proteins in plains. Nat. Rev. Genet. 2003. 4: 794-805.
13. Fischer, R., Stoger, E., Schillberg, S., Christou, P. and Twyman, R. M., Plant-based production of biopharmaceuticals. Curr. Opin. Plant Biol. 2004. 7: 152-158.
14. Maliga, P., Plastid transformation in higher plants. Annu. Rev. Plant Physiol. Plant Mol. Biol. 2004. 55: 289-313.
15. Tregoning, J., Maliga, P., Dougan, G. and Nixon, P. J., New advances in the production of edible plant vaccines: chloroplast expression of a tetanus vaccine antigen, TetC. Phytochemistry 2004. 65: 989-994.
16. Fairweather, N. F., Chatfield, S. N., Makoff, A. J., Strugnell, R. A., Bester, J., Maskell, D. J. and Dougan, G., Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier. Infect. Immun. 1990. 58: 1323-1326.
17. Tregoning, J. S., Nixon, P., Kuroda, H., Svab, Z., Clare, S., Bowe, F., Fairweather, N., Ytterberg, J., Wijk, K. J., Dougan, G. and Maliga, P., Expression of tetanus toxin Fragment C in tobacco chloroplasts. Nucleic Acids Res. 2003. 31: 1174-1179.
18. Stratford, R., Douce, G., Zhang-Barber, L., Fairweather, N., Eskola, J. and Dougan, G., Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus. Vaccine 2000. 19: 810-815.
19. McGhee, J. R. and Kiyono, H., Mucosal immunity to vaccines: current concepts for vaccine development and immune response analysis. Adv. Exp. Med. Biol. 1992. 327: 3-12.
20. Richter, L. J., Thanavala, Y., Arntzen, C. J. and Mason, H. S., Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol. 2000. 18: 1167-1171.
21. de Aizpurua, H. J. and Russell-Jones, G. J., Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding. J. Exp. Med. 1988. 167: 440-451.
22. Tamura, S. I. and Kurata, T., A proposal for safety standards for human use of cholera toxin (or Escherichia coli heat-labile enterotoxin) derivatives as an adjuvant of nasal inactivated influenza vaccine. Jpn. J. Infect. Dis. 2000. 53: 98-106.
23. Dougan, G., Huett, A. and Clare, S., Vaccines against human enteric bacterial pathogens. Br. Med. Bull. 2002. 62: 113-123.
24. Bardor, M., Faye, L. and Lerouge, P., Analysis of the N-glycosylation of recombinant glycoproteins produced in transgenic plants. Trends Plant Sci. 1999. 4: 376-380.
25. Sydenham, M., Douce, G., Bowe, F., Ahmed, S., Chatfield, S. and Dougan, G., Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccines. Infect. Immun. 2000. 68: 1109-1115.
26. Hussell, T., Spender, L. C., Georgiou, A., O'Garra, A. and Openshaw, P. J., Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. J. Gen. Virol. 1996. 77: 2447-2455.
27. Douce, G., Fontana, M., Pizza, M., Rappuoli, R. and Dougan, G., Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin. Infect. Immun. 1997. 65: 2821-2828.1